A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors
Clinical trial NCT05126927 · COMPLETED
Trial details
- NCT number
- NCT05126927
- Sponsor
- SmartNuclide Biopharma
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-02
- Primary completion
- 2022-01-19
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.